Literature DB >> 33492485

Pharmacological evaluation of prophylactic anti-microbial use in laparoscopic cholecystectomy; an open labelled study evaluating the concentrations of single dose intravenous ceftriaxone at serum and tissue level.

Sheikh Salim1,2, Malik Neeraj Kumar1, Chakar Dhar Tripathi1,2, Satya V Arya3, Veena Verma1, Karim Bushra Ahmed4, Girish Gulab Meshram1,2.   

Abstract

OBJECTIVE: The goal of administering preoperative systemic prophylactic antibiotics is to have the concentration in the tissues at its optimum level at the start and throughout the surgery. The rationale for the use of antibiotics is not well accepted; possible side effects and development of microbial resistance patterns are potential risks along with the financial burden. Therefore, the present study was conducted with the aim to clinically evaluate the serum and tissue concentration of single-dose prophylactic ceftriaxone during an ongoing laparoscopic cholecystectomy (LC) and to find out risk factors for post operative surgical site infections (SSI).
METHOD: It was an open labelled prospective study in 50 consecutive patients who underwent elective laparoscopic cholecystectomy under prophylactic cover of ceftriaxone. Serum and tissue concentration were estimated by High Performance Liquid Chromatography during the ongoing surgery. Subjects were observed for any post-operative complications including SSI.
RESULTS: Serum and tissue concentrations of ceftriaxone were significant at test value of 4 milligrams/Litre. Body mass index was significantly correlated with the tissue concentration of ceftriaxone at the time of incision. The rate of SSI was 2%. It significantly correlated with age more than 60 years, diabetes and infected bile.
CONCLUSION: A single prophylactic intra-venous dose of 1 g ceftriaxone immediately prior to skin incision in LC is good enough for prevention of SSI in Indian patients.

Entities:  

Keywords:  Ceftriaxone; Laparoscopic cholecystectomy; Prophylaxis

Year:  2021        PMID: 33492485     DOI: 10.1007/s00228-021-03093-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

1.  Comparative pharmacokinetics of ceftriaxone, cefmetazole and moxalactam during abdominal surgery.

Authors:  N Shinagawa
Journal:  J Chemother       Date:  1989-07       Impact factor: 1.714

2.  Evaluation of the role of prophylactic antibiotics in elective laparoscopic cholecystectomy: a prospective randomized trial.

Authors:  Sachin Anant Kuthe; Lileswar Kaman; Ganga Ram Verma; Rajinder Singh
Journal:  Trop Gastroenterol       Date:  2006 Jan-Mar

3.  Determinants of postoperative infection after laparoscopic cholecystectomy.

Authors:  Baris Yildiz; Osman Abbasoglu; Bulent Tirnaksiz; Erhan Hamaloglu; Aycan Ozdemir; Iskender Sayek
Journal:  Hepatogastroenterology       Date:  2009 May-Jun

4.  Factors influencing wound infection following laparoscopic cholecystectomy.

Authors:  V V Shindholimath; V Seenu; Rajinder Parshad; Rama Chaudhry; Arvind Kumar
Journal:  Trop Gastroenterol       Date:  2003 Apr-Jun

5.  The role of prophylactic antibiotics in elective laparoscopic cholecystectomy.

Authors:  Mehmet Uludag; Gurkan Yetkin; Bulent Citgez
Journal:  JSLS       Date:  2009 Jul-Sep       Impact factor: 2.172

  5 in total
  1 in total

1.  Variability in the serum and tissue concentrations of pre-incisional ceftriaxone for surgery in paediatric population and outcome of surgical-site infections; An open labelled, prospective, non-randomized, analytical study.

Authors:  Salim Sheikh; Ravinder Majoka; Chakra Dhar Tripathi; Veena Verma; Deepak Bagga; Bushra Ahmed Karim; Girish Gulab Meshram
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.